Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs
Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to …
Biopharma Insights
Top 10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology
The brain-computer interface (BCI) technology domain is constantly progressing as researchers and companies collaborate to devise inventive solutions that connect …
AI-Powered Peptide Discovery from Plant Sources Leads to a Breakthrough In Muscle Recovery
Nuritas, an innovator in AI-based peptide discovery from natural sources, has announced the results of a second clinical trial on …
AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery
The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The …
QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery
The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence …
Gandeeva Therapeutics and Moderna Join Forces to Explore AI-Enabled Cryo-EM Technology
Gandeeva Therapeutics, a precision medicine company specializing in designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and …
Portal Innovations Empowers Biotech Ventures in Chicago and Atlanta
Portal Innovations, headquartered in Chicago, is a biotech-focused venture capital company seeking to bolster the expansion of biotech startups in …
MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology
As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This …
AI Drug Discovery Financing Roundup: Unlearn.AI, Iktos, DenovAI, and More
The role of artificial intelligence (AI) in drug discovery is rapidly increasing, since it was shown to be able to …
Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery
Oxford Drug Design, a biotechnology company with core expertise in computer-aided drug design, has announced that it has been engaged …
The State of A.I. Drug Discovery and Its Future: Small Molecules, Vaccines, and Antibodies
Artificial intelligence (A.I.) and big data in a synergistic integration have led to promising results in new drug development by …
The Potential of Artificial Intelligence to Transform the European Life Sciences Landscape (with a Caveat)
The adoption of artificial intelligence (AI) in life sciences has been rapidly expanding across the globe, and the European Union …
